Xtant Medical Holdings, Inc.
XTNT
$0.35
-$0.03-7.95%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -143.17% | 115.23% | 130.23% | 109.96% | -37.41% |
| Total Depreciation and Amortization | -9.90% | 9.08% | 23.65% | 11.21% | 14.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.37% | -6.16% | -4.97% | 3.54% | 164.80% |
| Change in Net Operating Assets | 3.02% | 5.69% | 43.05% | 23.93% | 47.23% |
| Cash from Operations | -62.03% | 288.24% | 205.46% | 158.11% | 109.63% |
| Capital Expenditure | 70.78% | 69.43% | 42.09% | 30.10% | -125.33% |
| Sale of Property, Plant, and Equipment | -20.20% | -30.72% | -39.43% | -18.80% | -1.98% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 456.49% | 558.73% | 311.77% | 148.43% | 50.31% |
| Total Debt Issued | -27.40% | -31.88% | -14.94% | -9.09% | -1.54% |
| Total Debt Repaid | 16.07% | 7.68% | -3.98% | -10.14% | -10.68% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -68.10% |
| Repurchase of Common Stock | 45.50% | 25.29% | 29.21% | 26.98% | 20.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.53% | 67.87% | 82.49% | 94.14% | 88.71% |
| Cash from Financing | -386.22% | -319.81% | -159.54% | -139.89% | -83.04% |
| Foreign Exchange rate Adjustments | 331.19% | 327.45% | 255.70% | -224.32% | -194.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.98% | 728.85% | 3,627.18% | 313.77% | 51.36% |